Marc Ullman was interviewed for a Nutraingredients-USA article entitled, “FTC Begins Refunding Consumers in False Memory Claims Case.” The article discusses a product named CogniPrin, promoted via radio segments that were created to sound like radio talk shows.

Marc noted that using radio ads to promote nutritional products can create compliance issues. “There is a

On Wednesday, April 25, Rivkin Radler, in conjunction with the Gitenstein Institute for Health Law and Policy, will present “Defending an FCA Allegation: Forewarned Is Forearmed.” The panel will deconstruct real, unsealed False Claims Act cases to reveal how healthcare companies can protect themselves against allegations of fraudulent medical billing practices.

Rivkin Radler attorneys Brian

Geoffrey Kaiser and John Queenan will be joined by Paul Kaufman, VP of Northwell Health’s Office of Legal Affairs, and Patrick Pilch, the head of BDO’s healthcare advisory practice, to present “Defending an FCA Allegation: Forewarned is Forearmed.” The panel discussion will be moderated by Rivkin Radler partner Brian Bank.

The presentation, co-sponsored by the Gitenstein

Marc Ullman was quoted in a NutraIngredients-USA article entitled, “CRN says more enforcement should go with FDA’s plan to step up package screenings.” The article discusses the FDA’s challenges in monitoring the large influx of packages being brought into the country.

Marc notes another recurring issue that FDA needs to address, “Along with the increased

Marc Ullman was quoted in a NutraIngredients-USA article entitled, “Department of Justice joins chorus asking court to turn down Amarin appeal.” The article discusses the Department of Justice’s request for the federal appeals court not to rule in favor of the drug maker’s attempt to force the International Trade Commission (ITC) to hear its plea that

Marc Ullman will be an instructor at the Dietary Supplement Good Manufacturing Practices (GMP) Compliance Seminar, which takes place on April 4-5, 2018 in Denver, Co.

At this seminar you will learn the requirements of the final rule and understand how they differ from the proposed rule that was published in March 2003.  You will

Chris Kutner shared his perspective with HealthLeaders Media on the planned merger of Cigna with pharmacy benefit manager Express Scripts.

His comments are informed both by his work at Rivkin Radler and his experience as general counsel at Vytra.

Click here to read the article.

Marc Ullman, a regular presenter at SupplySide East, the East Coast’s large ingredients trade show, will again weigh in at this year’s show. On Tuesday, April 10, in New York City, he will  present on the topic, “25 Years after DSHEA & the NDI Process Still Broken.”

Marc will discuss how, 25 years and two

Marc Ullman was quoted in a Natural Products Insider article entitled, “Basic Omissions Doom Many Dietary Supplement Ingredient Notices to FDA.” The article discusses why the FDA objected to the majority of pre-market notifications for new dietary ingredients (NDIs) in 2017.

Marc notes, “It isn’t a surprise when you submit an incomplete form to anyone that

Evan H. Krinick, Managing Partner of Rivkin Radler LLP, has welcomed four new attorneys, Christina M. Bezas, David I. Gise, Robert C. Kern Jr. and Amanda S. Reynolds to the firm.

Christina M. Bezas, of Long Beach, N.Y., is an Associate in the Insurance Fraud Practice Group. Christina prosecutes complex civil lawsuits under the federal